Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents

<p>In this paper analysis of anemia correction efficacy in multiple myeloma patients was shown. Patients (n = 68) treated with epoetin alfa (recombinant erythropoietin (rEPO)) 150 IU/kg subcutaneously three times per week (no more 20 weeks) were included in the study group. Patients who did no...

Full description

Bibliographic Details
Main Authors: N. A. Romanenko, N. A. Potikhonova, K. M. Abdulkadyrov
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Онкогематология
Subjects:
Online Access:http://oncohematology.abvpress.ru/index.php/ongm/article/view/58